ArticleMolecules (Basel, Switzerland)2026
Direct Phasing of Protein Crystals with Hybrid Difference Map Algorithms.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Direct Phasing of Protein Crystals with Continuous Iterative Projection Algorithms and Refined Envelope Reconstruction.Biomolecules · 2026Article
- Direct Phasing of Protein Crystals with Hybrid Difference Map Algorithms.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct methods for solving protein crystal structures from X-ray diffraction data provide an essential approach for validating predicted models while avoiding external model bias. Nevertheless, traditional iterative projection algorithms, including the widely used Difference Map (DiffMap), are often limited by modest phase retrieval success rates. To address this limitation, we introduce a novel Hybrid Difference Map (HDM) algorithm that synergistically combines the strengths of DiffMap and the Hybrid Input-Output (HIO) method through six distinct iterative update rules. HDM retains an optimized DiffMap-style relaxation term for fine-grained density modulation in protein regions while adopting HIO's efficient negative feedback mechanism for enforcing the solvent flatness constraint. Using the transmembrane photosynthetic reaction center 2uxj as a test case, the first HDM formula, HDM-f1, successfully recovered an atomic-resolution structure directly from random phases under a conventional full-resolution phasing scheme, demonstrating the robust phasing capability of the approach. Systematic evaluation across 22 protein crystal structures (resolution 1.5-3.0 Å, solvent content ≥ 60%) revealed that all six HDM variants outperformed DiffMap, achieving 1.8-3.5× higher success rates (average 2.8×), performing on par with or exceeding HIO under a conventional phasing scheme. Further performance gains were achieved by integrating HDM with advanced strategies: resolution weighting and a genetic algorithm-based evolutionary scheme. The genetic evolution strategy boosted the success rate to nearly 100%, halved the median number of iterations required for convergence, and reduced the final phase error to approximately 35° on average across test structures through averaging of multiple solutions. The resulting electron density maps were of high interpretability, enabling automated model building that produced structures with a backbone RMSD of less than 0.5 Å when compared to their PDB-deposited counterparts. Collectively, the HDM algorithm suite offers a robust, efficient, and adaptable framework for direct phasing, particularly for challenging cases where conventional methods struggle. Our implementation supports all space groups providing an accessible tool for the broader structural biology community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.